You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
In ancient Japan, a witch named Hannya seeks to use the warrior-monk Ningen's enlightened body and spirit to resurrect the demon-samurai Atsumori and unleash an era of chaos! After leaving the safety of his temple to protect defenseless commoners, Ningen soon finds that several colorful bounty hunters are on his trail! * Revisiting the world of 365 Samurai and a Few Bowls of Rice! * His last book was nominated for a teens award by YALSA. New standalone adventure!
Employs full-page panels to tell the story of an Edo-era swordsman's quest for survival and enlightenment. When Ningen leaves his dojo at the request of his master - to travel the world and grow as a swordsman - he embarks on a journey that becomes a metaphor for the cycle of life and every human's spiritual growth.
Artist Jp Kalonji's hard cover sketchbook.
The HIV/sexually transmitted infection (STI) syndemics and the unmet need for modern contraceptive methods continue to pose significant health risks for women and other people worldwide. As awareness of the need to address these interlinked risks has increased, the need for new technologies that combine protection against unintended pregnancy, HIV and other STIs is a growing research priority. Multipurpose Prevention Technologies (MPTs) are products that simultaneously prevent HIV, other STIs, and/or unintended pregnancy. They have power to revolutionize women's health by providing prevention for multiple indications.
Globally, women of reproductive age face two overlapping issues that have a significant impact on their health and well-being: unintended pregnancy and sexually transmitted infections (STIs), including HIV. A growing body of research indicates that the majority of women across geographies, ages, racial and ethnic backgrounds would prefer a multipurpose prevention technology (MPT) that combines protection against pregnancy and HIV/STIs versus individual products for contraception and disease prevention. Currently, male and female condoms are the only available MPTs. A wider range of MPT options will help women select methods that they are less apt to discontinue, as well as increase uptake by...
This 2024 update of the Provider module for oral and long-acting PrEP of the WHO PrEP Implementation Tool replaces the 2017 Clinical Module. The module integrates clinical service delivery guidance for all three WHO recommended PrEP products (oral PrEP, the dapivirine vaginal ring and long acting injectable cabotegravir). It provides practical support and important considerations for the safe and effective PrEP provision by a range of providers, including physicians, nurses, clinical officers, community health workers, pharmacists and lay and peer providers, in either clinical or community settings.
This brief report summarizes recent information on HIV drug resistance (HIVDR) in the era of integrase-strand transfer inhibitors (INSTI) for HIV prevention and treatment. In this report, WHO documents high levels of HIV viral load suppression (>90%) in populations receiving dolutegravir (DTG)-containing antiretroviral therapy (ART). However, recent observational data reveal that HIVDR to DTG is emerging at levels exceeding those observed in clinical trials. Few countries have reported people not achieving viral suppression while receiving DTG-containing ART. However, amongst the surveys reported, levels of DTG resistance ranged from 3.9% to 8.6%, with levels as high as 19.6% observed among ...
The report titled The Urgency of Now: AIDS at a Crossroads, demonstrates the HIV response is at a crossroads: success or failure will be determined by which path leaders take. The report shows that the decisions leaders make this year will determine whether AIDS is ended as a public health threat by 2030. Taking the wrong path, by limiting resourcing or clamping down on human rights, would lead the pandemic to continue to grow, costing millions more lives and undermining global health security.
Over half of HIV infections globally occur among cisgender women. High HIV incidence among young (ie, 15–30 years old) African cisgender women persists during pregnancy and postpartum, and there is evidence that HIV acquisition risk more than doubles during this period. A new HIV infection has important short- and long-term consequences for the mother’s health. Acute maternal HIV infection is also associated with increased vertical transmission risk, making prevention of HIV among pregnant and breastfeeding populations a global health priority. As access to antiretroviral therapy continues to expand, new—and often undiagnosed—maternal HIV infections during pregnancy and breastfeeding...